PsiThera
Watertown, Massachusetts, United States · Biotechnology · 34 employees
PsiThera is a biotechnology company harnessing biologically relevant protein states and computational intelligence to create oral drugs for immune and inflammatory diseases — therapeutic areas long reliant on injectables. Integrating biophysics, computational modeling, and mechanistic biology enables PsiThera’s expert drug hunters to discover new therapeutic opportunities and optimized drugs. The
Funding history
- Series series a — $47.5M — Dec 2025
Recent signals
- Dec 16, 2025: Raised $47.5M in Series series a
- Dec 10, 2025: PsiThera Appoints Eric Shaff as Chief Executive Officer
See plans & pricing → Track PsiThera’s funding, hiring, and signals — with verified contacts — on Fundz.